STAAR Surgical Company (STAA)
STAAR Surgical Company Market Cap: 298.65M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
STAA Market Cap Rankings
| Overall | 41st percentile | 2721 of 4665 |
| Sector | 55th percentile | 237 of 527 in Healthcare |
| Industry | 50th percentile | 34 of 69 in Medical Instruments & Supplies |
STAA Market Cap Range, Past 5 Years
| Minimum | 29.50M | Mar 2009 |
| Maximum | 392.05M | Mar 2012 |
| Average | 165.61M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these STAA related companies
STAA News
STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
May 29, 6:30AM PR Newswire
May 29, 6:30AM PR Newswire
$STAA http://stks.co/408c consolidation after down move, under 8.50 has target of 7.90 and 7.08
about 5 days ago by harmongreg
about 5 days ago by harmongreg
B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference
May 21, 4:16PM PR Newswire
May 21, 4:16PM PR Newswire
STAAR Surgical To Present At The 13th Annual B. Riley & Co. Investor Conference
May 16, 6:30AM PR Newswire
May 16, 6:30AM PR Newswire
Im heading for the exit on $staa down .15c dont like the action. Couldnt hold 20ema
about 21 days ago by MrDayer
about 21 days ago by MrDayer
Listen to $STAA STAAR Surgical at Deutsche Bank AG Health Care Conference - live at 02:10 PM, ondemand after - http://stks.co/3j2t
about 24 days ago by earningscast
about 24 days ago by earningscast
Canaccord Genuity Reiterates a 'Buy' on STAAR Surgical (STAA); Mixed Q1
May 03, 9:51AM Street Insider
May 03, 9:51AM Street Insider
$STAA is getting tightly coiled here and looked like it's ready to make a big b/o soon
about 30 days ago by OptimusPrime
about 30 days ago by OptimusPrime
$STAA 1Q earnings, ICL revenue up 25% YoY, ICL Revenue in Asia/Pacific Region Up 50%, Record Gross Margin of 70.3% http://stks.co/3dLW
about 30 days ago by evcgroup
about 30 days ago by evcgroup
STAAR Surgical to Present at the Deutsche Bank 37th Annual Health Care Conference
May 01, 6:30AM PR Newswire
May 01, 6:30AM PR Newswire
STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Apr 25, 4:05PM PR Newswire
Apr 25, 4:05PM PR Newswire
Canaccord Genuity reiterates a 'Buy' on STAAR Surgical $STAA W/ price target of $14.50.
about 39 days ago by ChiBullsTrader
about 39 days ago by ChiBullsTrader
Canaccord Genuity Reiterates a 'Buy' on STAAR Surgical (STAA); Attractive Small-cap Growth Idea
Apr 23, 9:16AM Street Insider
Apr 23, 9:16AM Street Insider
$STAA celebrates over 300,000 uccessful Visian ICL implants at ASCRS -Over 75,000 of these lenses have been the Visian Toric ICL
about 42 days ago by ChiBullsTrader
about 42 days ago by ChiBullsTrader
STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
Apr 20, 6:30AM PR Newswire
Apr 20, 6:30AM PR Newswire
$STAA forms bullish "Continuation Diamond" chart pattern. http://stks.co/3LWt
about 49 days ago by RecogniaEvents
about 49 days ago by RecogniaEvents
$STAA filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Klb
about 49 days ago by MarketBrief
about 49 days ago by MarketBrief
$STAA filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3JXi
about 50 days ago by MarketBrief
about 50 days ago by MarketBrief
$STAA filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3IYM
about 51 days ago by MarketBrief
about 51 days ago by MarketBrief
Canaccord Genuity Reiterates a 'Buy' on STAAR Surgical (STAA); Projecting Strong Growth
Mar 07, 9:07AM Street Insider
Mar 07, 9:07AM Street Insider
STAAR Surgical Previews Strong Visian® ICL™ Presence at the Upcoming World Ophthalmology Congress
Feb 14, 6:30AM PR Newswire
Feb 14, 6:30AM PR Newswire
STAAR Surgical Announces Fourth Quarter 2011 Results Release Date and Conference Call and Webcast
Feb 13, 6:30AM PR Newswire
Feb 13, 6:30AM PR Newswire
STAAR Surgical to Present at the Canaccord Genuity 6th Annual Medical Device Conference
Dec 01, 6:30AM PR Newswire
Dec 01, 6:30AM PR Newswire
STAAR Surgical receives approval for Toric Collamer IOL marketing in Europe
Nov 16, 6:40AM FlyOnTheWall
Nov 16, 6:40AM FlyOnTheWall
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| STAA | 8.25 | -0.24 | -2.83% | 307.34M |
| ST | 30.06 | -0.65 | -2.12% | 5.419B |
| SSYS | 44.44 | -3.08 | -6.48% | 1.012B |
| SSY | 0.93 | +0.00 | +0.00% | 8.788M |
| SSW | 15.92 | -0.32 | -1.97% | 1.021B |
| SSS | 47.89 | -1.46 | -2.96% | 1.430B |
| SPG | 143.67 | -3.85 | -2.61% | 43.92B |
| SPEX | 0.75 | -0.03 | -3.85% | 3.12M |
| SPCHB | 1.716 | +0.03 | +1.54% | 3.054M |
| SPCHA | 1.22 | -0.15 | -10.95% | 15.14M |
